4//SEC Filing
FITZPATRICK LINDA A 4
Accession 0001415889-25-007184
CIK 0001382101other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:12 PM ET
Size
10.0 KB
Accession
0001415889-25-007184
Insider Transaction Report
Form 4
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+9,125→ 94,025 total - Tax Payment
Common Stock
2025-03-04$1.42/sh−3,748$5,322→ 90,277 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-04−9,125→ 9,125 totalExp: 2026-03-04→ Common Stock (9,125 underlying)
Holdings
- 10,383(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
- [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001188953
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:12 PM ET
- Size
- 10.0 KB